ArticleJournal of extracellular biology2025
Extracellular Vesicles From a Model of Melanoma Cancer-Associated Fibroblasts Induce Changes in Brain Microvascular Cells Consistent With Pre-Metastatic Niche Priming.
Article in Journal of extracellular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cancer-Associated Fibroblasts Functions as Multifunctional Architects of the Tumor Stroma and Represent Emerging Therapeutic Vulnerabilities.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Extracellular Vesicles From a Model of Melanoma Cancer-Associated Fibroblasts Induce Changes in Brain Microvascular Cells Consistent With Pre-Metastatic Niche Priming.Journal of extracellular biology · 2025Article
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
Abstract
Malignant melanoma has one of the lowest 5-year survival rates of any cancer and is characterised by its high invasiveness and metastatic potential, with especially poor outcomes in patients who develop brain metastases. Crosstalk between melanoma cells and cells of the tumour microenvironment (TME), including cancer-associated fibroblasts (CAFs), is a central driver of disease progression. While the role of melanoma-derived small extracellular vesicles (sEVs) in reprogramming stromal cells has been well documented, the reciprocal effects of CAF-derived sEVs remain less clear. Here, using an in vitro model of melanoma CAFs, we show that CAF sEVs alter melanoma cells and fibroblasts to promote oncogenic traits and remodel endothelial cells, including brain microvascular cells, in ways consistent with early pre-metastatic niche (PMN) changes. Multi-omics cargo profiling revealed significant differential expression of proteins and RNAs linked to extracellular matrix organisation, vascular remodelling, and patient outcomes, with functional validation identifying THBS1 as an EV cargo that restrains endothelial sprouting while potentially promoting barrier destabilisation. Together, these findings suggest that CAF-derived sEVs contribute to local and distal PMN remodelling, highlight their potential as therapeutic targets, and identify EV cargoes with promise as circulating biomarkers in melanoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.